Tiverton Asset Management’s Elevance Health ELV Stock Holding History

Tiverton Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.12M	Buy	12,971 +2,288	+21%	+$627K	0.11%	162
2019 Q2	$3.01M	Buy	10,683 +3,109	+41%	+$849K	0.11%	160
2019 Q1	$2.17M	Buy	7,574 +72	+1%	+$20.8K	0.09%	165
2018 Q4	$1.97M	Hold	7,502	–	–	0.12%	127
2018 Q3	$2.06M	Sell	7,502 -16	-0.2%	-$4.15K	0.1%	139
2018 Q2	$1.79M	Buy	7,518 +4,099	+120%	+$949K	0.09%	139
2018 Q1	$751K	Buy	3,419 +15	+0.4%	+$3.52K	0.05%	176
2017 Q4	$766K	Buy	+3,404	New	+$725K	0.05%	202

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Tiverton Asset Management's ELV Position: Q3 2019 in Review

Tiverton Asset Management increased its Elevance Health (ELV) stake by 21% in Q3 2019, buying an estimated $627K and bringing the position to 12,971 shares worth $3.12M. The position accounts for 0.11% of the portfolio, ranked #162.

Tiverton Asset Management first reported a position in ELV in Q4 2017 and has held it in 8 quarters since. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Tiverton Asset Management held 12,971 shares of Elevance Health worth $3.12M as of Q3 2019.
Tiverton Asset Management bought 2,288 Elevance Health shares in Q3 2019, an estimated $627K.
Elevance Health made up 0.11% of Tiverton Asset Management's portfolio in Q3 2019, its #162 holding.
Tiverton Asset Management first reported a position in Elevance Health in Q4 2017 and has held it in 8 quarters since.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.